tiprankstipranks
Jagsonpal Pharmaceuticals Ltd. (IN:JAGSNPHARM)
:JAGSNPHARM
India Market
JAGSNPHARM
Jagsonpal Pharmaceuticals Ltd.
RESEARCH TOOLSreports
Want to see IN:JAGSNPHARM full AI Analyst Report?

Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) Income Statement

2 Followers

Jagsonpal Pharmaceuticals Ltd. Income Statement

Last quarter (Q2 2026), Jagsonpal Pharmaceuticals Ltd.'s total revenue was ₹744.65M, a decrease of -0.30% from the same quarter last year. In Q2, Jagsonpal Pharmaceuticals Ltd.'s net income was ₹125.74M. See Jagsonpal Pharmaceuticals Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Mar 23Mar 22
Total Revenue
₹ 2.87B₹ 2.69B₹ 2.09B₹ 2.37B₹ 2.18B
Gross Profit
₹ 1.83B₹ 1.72B₹ 652.59M₹ 1.44B₹ 1.28B
Operating Expenses
₹ 1.34B₹ 709.33M₹ 438.55M₹ 1.10B₹ 1.04B
Depreciation and Amortization
₹ 94.44M₹ 81.31M₹ 16.63M₹ 11.75M₹ 15.26M
EBITDA
₹ 679.90M₹ 510.71M₹ 323.46M₹ 363.96M₹ 284.53M
Operating Income
₹ 486.30M₹ 435.49M₹ 214.04M₹ 343.30M₹ 245.45M
Other Income/Expenses
₹ 88.88M₹ 263.10M₹ 84.65M₹ 4.78M₹ 20.97M
Pretax Income
₹ 575.18M₹ 698.59M₹ 298.69M₹ 348.08M₹ 266.42M
Net Income
₹ 430.82M₹ 553.61M₹ 224.63M₹ 267.21M₹ 188.55M
Per Share Metrics
Basic EPS
₹ 6.40₹ 8.26₹ 3.40₹ 4.08₹ 2.88
Diluted EPS
₹ 6.31₹ 8.22₹ 3.39₹ 4.08₹ 2.88
Weighted Average Shares Outstanding
 67.32M 67.35M 66.38M 65.50M 65.50M
Weighted Average Shares Outstanding (Diluted)
 68.28M 67.35M 66.30M 65.50M 65.50M
Currency in INR

Jagsonpal Pharmaceuticals Ltd. Earnings and Revenue History